SALT LAKE CITY / Sep 11, 2023 / Business Wire / Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Sidoti Small Cap Virtual Conference.
Management will participate in a fireside chat presentation on Wednesday, September 20, 2023 at 1:00pm EST. The presentation will be webcast live and may be accessed through the following link: https://sidoti.zoom.us/webinar/register/WN_b584FfbtSOy7pvg9PiEx5g
A replay of the presentation will be available on Varex’s website at www.vareximaging.com/news. The replay will be available for 90 days after the presentation.
About Varex
Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. With a 70+ year history of successful innovation, Varex’s products are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers incorporate Varex’s X-ray sources, digital detectors, connecting devices and imaging software in their systems to detect, diagnose, protect and inspect. Headquartered in Salt Lake City, Utah, Varex employs approximately 2,400 people located in North America, Europe, and Asia. For more information visit vareximaging.com.
| Last Trade: | US$15.59 |
| Daily Change: | -0.84 -5.11 |
| Daily Volume: | 1,029,331 |
| Market Cap: | US$633.270M |
March 01, 2024 December 29, 2023 | |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
